Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 27027-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- CDK7 antibody
- Antibody type
- Polyclonal
- Description
- CDK7 antibody (Cat. #27027-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Phosphoproteome Reveals the Role of Baicalin in Alleviating rPVL-Induced Cell Cycle Arrest in BMECs.
IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression.
CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma.
TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors.
Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach.
TRF1 uses a noncanonical function of TFIIH to promote telomere replication.
Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction.
Hou L, Li J, Wang J, You Q, Zhang D, Zhou X
Microorganisms 2025 Jul 16;13(7)
Microorganisms 2025 Jul 16;13(7)
IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression.
Luo X, Xie L, Ma X, Chen N, Xu J, Jiang X, Liu X, Yang Y, Liu T, Yi P, Xu J
Communications biology 2025 Apr 29;8(1):680
Communications biology 2025 Apr 29;8(1):680
CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma.
Luo CH, Hu LH, Liu JY, Xia L, Zhou L, Sun RH, Lin CC, Qiu X, Jiang B, Yang MY, Zhang XH, Yang XB, Chen GQ, Lu Y
Nature communications 2024 Dec 5;15(1):10594
Nature communications 2024 Dec 5;15(1):10594
TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
Gao Y, Hou J, Fei X, Ren L, Lu R, Liu P, Liu S, Zhu C, Wang X, Pan Y
Cellular signalling 2024 Aug;120:111227
Cellular signalling 2024 Aug;120:111227
Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors.
Zhu F, Lu Z, Tang W, Zhao G, Shao Y, Lu B, Ding J, Zheng Y, Fang L, Li H, Wang G, Chen R, Zheng J, Chai D
Journal for immunotherapy of cancer 2024 Aug 28;12(8)
Journal for immunotherapy of cancer 2024 Aug 28;12(8)
Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach.
Fei X, Liu S, Liu P, Wang X, Zhu C, Hou J, Cai J, Pan Y
Frontiers in oncology 2022;12:1043161
Frontiers in oncology 2022;12:1043161
TRF1 uses a noncanonical function of TFIIH to promote telomere replication.
Yang Z, Sharma K, de Lange T
Genes & development 2022 Sep 1;36(17-18):956-969
Genes & development 2022 Sep 1;36(17-18):956-969
Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction.
Huang CS, Xu QC, Dai C, Wang L, Tien YC, Li F, Su Q, Huang XT, Wu J, Zhao W, Yin XY
ACS nano 2021 Sep 28;15(9):14744-14755
ACS nano 2021 Sep 28;15(9):14744-14755
No comments: Submit comment
No validations: Submit validation data